Time for a New Slate in Tardive Dyskinesia Research

Mov Disord. 2020 May;35(5):752-755. doi: 10.1002/mds.28003. Epub 2020 Feb 18.

Authors

Pierre J Blanchet^{1

2}, Daniel Lévesque³

Affiliations

¹ Department of Stomatology, Faculty of Dental Medicine, University of Montreal, Montreal, QC, Canada.
² Department of Medicine, University of Montreal Hospital Centre (CHU Montreal), Montreal, QC, Canada.
³ Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada.

PMID: 32067258
DOI: 10.1002/mds.28003

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antipsychotic Agents* / adverse effects
Dyskinesia, Drug-Induced* / drug therapy
Dyskinesia, Drug-Induced* / etiology
Gastrointestinal Agents / therapeutic use
Humans
Tardive Dyskinesia* / chemically induced
Tardive Dyskinesia* / drug therapy

Substances

Antipsychotic Agents
Gastrointestinal Agents

Grants and funding